You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 6, December 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Study of Serum Antinuclear Factor in Uveitis

YOSHITOSHI KUROSE, MD; JOSEPH MICHON, JR., MD; IRVING H. LEOPOLD, MD

Arch Ophthalmol. 1964;72(6):844-849.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Some evidence suggests that uveitis may be related to an autoimmune process.1-5 Previous reports from this laboratory (Hallett, Wolkowicz, Leopold et al,6 1960; Hallett, Wolkowicz, Leopold, et al, 19622) have described the presence of a rheumatoid factor in 20% of patients with uveitis, demonstrated by the latex agglutination test and the presence of an autoimmune component in 52% by the autoimmune complement fixation test. From those studies Leopold3 suggested that endogenous uveitis could be propagated if not initiated by an autoimmune response.

Autoimmune diseases have been broadly classified into two categories by Burnet7,8: "disturbed antigen" diseases and "disturbed tolerance" diseases. The former are ex-emplified by Hashimoto's thyroiditis and the latter by systemic lupus erythematosus (SLE). It has been suggested that autoimmune uveitis may be classified into the category of "disturbed antigen" diseases.5

Since the description of the lupus erythematosus cell phenomenon by Hargraves . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

From the Research Department, Wills Eye Hospital.


Footnotes

Submitted for publication April 27, 1964.

This investigation was supported by Public Health Service research grants No. (2B-5076) and No. FR-5510 from the National Institutes of Health, and the Hartford Foundation.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.